levodopa造句
1. This explains the increased sensitivity to levodopa that some patients exhibit after a period off the drug.
2. Cardiac arrhythmias rarely result from levodopa administration to patients who have a predisposition related to underlying cardiac disease.
3. Hence patients requiring smaller doses of levodopa who are troubled with nausea cardiac arrhythmias, or hypotension may use this dosage form.
4. In rare instances, parkinsonian patients taking levodopa experience increased libido as a side effect.
5. After a period of time, levodopa loses its effectiveness and starts to wear off before the next dose is due.
6. Also, levodopa can produce bad effects in some people.
7. Second, levodopa therapy is not associated with neurotoxicity.
8. Objective To observe the effects of levodopa on strabismic amblyopia model eyes in cats, and explore amblyopia pathogenesis.
9. Objective To observe the effects of levodopa (LDP) on strabismic amblyopia model eyes in cats, and explore amblyopia pathogenesis.
10. The invention relates to a preparation method of an L-DOPA (levodopa) modified organic-inorganic composite medicine slow release stent coating.
11. To establish a method for determination of Levodopa in Mucuna macrocarpa Wall by HPLC.
12. When it reaches the brain, levodopa is changed to dopamine.
13. Low dose levodopa and dopamine agonists are effective in controlling most symptoms of the disorder.
14. Although levodopa helps deal with the signs of the disease.
15. The other side effects described in the section on levodopa may also occur with bromocriptine administration.
16. The drug produces more psychiatric effects and probably more cardiac toxicity than does levodopa.
17. Aim: To study the efficacy and safety of entacapone as an adjunct to levodopa treatment in parkinsonian patients with wearing-off motor fluctuations.
18. Methods To observe the clinical manifestation, auxiliary test and the response on the treatment of levodopa in 6 patients from 4 families.
19. Objective To investigate and research the application of insulin and levodopa in growth hormone releasing test .
20. Aim To establish the model of oxidative damage in brain of Parkinsons disease (PD) rats induced by levodopa (L-DOPA) with microdialysis technique.
21. The diagnosis of restless legs in based on its characteristic clinical presentation. Levodopa and dopamine receptor agonist were effective.
22. To prevent this from happening, other substances can be combined with levodopa.
23. The investigators call for clinical assessment of neuropathy in patients treated with levodopa on a long-term basis.
24. The three-month, multi-center study in Japan involved 279 Parkinson disease patients who weren't responding well to the commonly used drug, levodopa, to manage their symptoms.
25. Objective To explore the clinical curative effect of children's amblyopia treated with levodopa and carbidopa.
26. If we could find the right channel and subdue it then we could get more effective treatment with levodopa without any side effects.
27. An overactivation of glutamate signals, caused by treatment with levodopa, probably contributes to the development of dyskinesia.
28. Consult a healthcare practitioner if liver impaired, have a history of non-melanoma skin cancer, or are taking levodopa or tetracyclines.
29. Results: We identified 126 incident Parkinson disease patients treated with levodopa for at least 2 months.
30. The most commonly used drug to treat the disease is levodopa.
12